BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29891536)

  • 21. G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.
    Mazharian A; Bertin O; Sarkar A; Augros J; Bornert A; Loubière C; Jönsson F; Warwicker J; Abbott WM; Dushek O; Vayne C; Rauova L; Fütterer K; Rollin J; Poncz M; Senis YA
    bioRxiv; 2024 May; ():. PubMed ID: 38798354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
    Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
    J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates.
    Bone H; Dechert U; Jirik F; Schrader JW; Welham MJ
    J Biol Chem; 1997 May; 272(22):14470-6. PubMed ID: 9162089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets.
    Cicmil M; Thomas JM; Leduc M; Bon C; Gibbins JM
    Blood; 2002 Jan; 99(1):137-44. PubMed ID: 11756163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel G6B gene variant causes familial autosomal recessive thrombocytopenia and anemia.
    Melhem M; Abu-Farha M; Antony D; Madhoun AA; Bacchelli C; Alkayal F; AlKhairi I; John S; Alomari M; Beales PL; Alsmadi O
    Eur J Haematol; 2017 Mar; 98(3):218-227. PubMed ID: 27743390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development.
    Kuo E; Park DK; Tzvetanova ID; Leiton CV; Cho BS; Colognato H
    J Neurochem; 2010 Apr; 113(1):200-12. PubMed ID: 20132481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect.
    Cheng Y; Ouyang W; Liu L; Tang L; Zhang Z; Yue X; Liang L; Hu J; Luo T
    Phys Chem Chem Phys; 2024 Mar; 26(12):9155-9169. PubMed ID: 38165855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs of human leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment.
    Verbrugge A; Ruiter Td Td; Clevers H; Meyaard L
    Int Immunol; 2003 Nov; 15(11):1349-58. PubMed ID: 14565933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.
    Hua CT; Gamble JR; Vadas MA; Jackson DE
    J Biol Chem; 1998 Oct; 273(43):28332-40. PubMed ID: 9774457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions.
    Bellio M; Garcia C; Edouard T; Voisin S; Neel BG; Cabou C; Valet P; Mori J; Mazharian A; Senis YA; Yart A; Payrastre B; Severin S
    Blood; 2019 Dec; 134(25):2304-2317. PubMed ID: 31562133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1.
    Bléry M; Kubagawa H; Chen CC; Vély F; Cooper MD; Vivier E
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2446-51. PubMed ID: 9482905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2.
    Xu X; Hou B; Fulzele A; Masubuchi T; Zhao Y; Wu Z; Hu Y; Jiang Y; Ma Y; Wang H; Bennett EJ; Fu G; Hui E
    J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32437509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fer and Fps/Fes participate in a Lyn-dependent pathway from FcepsilonRI to platelet-endothelial cell adhesion molecule 1 to limit mast cell activation.
    Udell CM; Samayawardhena LA; Kawakami Y; Kawakami T; Craig AWB
    J Biol Chem; 2006 Jul; 281(30):20949-20957. PubMed ID: 16731527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro.
    Newland SA; Macaulay IC; Floto AR; de Vet EC; Ouwehand WH; Watkins NA; Lyons PA; Campbell DR
    Blood; 2007 Jun; 109(11):4806-9. PubMed ID: 17311996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H-2Dd engagement of Ly49A leads directly to Ly49A phosphorylation and recruitment of SHP1.
    Daws MR; Eriksson M; Oberg L; Ullén A; Sentman CL
    Immunology; 1999 Aug; 97(4):656-64. PubMed ID: 10457220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.